Immunome Inc (IMNM)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Immunome Inc-Aktie (IMNM)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	37.22% 4.015	2.926	2.738	2.91	2.364
Operating Expenses	6.16% 50.49	47.56	85.71	53.43	42.37
Benefits Costs and Expenses	100.00% -	44.57	82.99	-	-
Costs And Expenses	13.30% 50.49	44.57	82.99	53.43	42.37
Provision For Loan, Lease, And Other Losses	-	-	-	-	-
Operating Income/Loss	4.13% -46.48	-44.64	-82.97	-50.52	-40.01
Net Interest Income/Expense	2.84% 3.081	2.996	2.721	3.422	3.887
Interest Income/Expense After Provision For Losses	2.84% 3.081	2.996	2.721	3.422	3.887
Income/Loss From Continuing Operations Before Tax	109.64% 4.015	-41.64	-80.25	2.91	-36.12
Income/Loss From Continuing Operations After Tax	4.22% -43.40	-41.64	-80.25	-47.10	-36.12
Net Income/Loss	4.22% -43.40	-41.64	-80.25	-47.10	-36.12
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	9.57% 87.01	79.41	1.3998	60.21	59.94
Diluted Average Shares	9.57% 87.01	79.41	1.3998	60.21	59.94
Basic Earnings Per Share	3.85% -0.50	-0.52	-1.28	-0.78	-0.60
Diluted Earnings Per Share	3.85% -0.50	-0.52	-1.28	-0.78	-0.60
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$38.92

1.38%

GMAB

$30.45

1.36%

INCY

$102.06

0.29%

BNTX

$95.59

1.42%

ONC

$347.72

0.45%

INSM

$198.76

0.44%